Skip to main content

Advertisement

SpringerLink
Log in

Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: an extensive MM\GBSA-based screening, and MD simulation study

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Cervical cancer is a significant cause of morbidity and mortality in women worldwide. Despite the availability of effective therapies, the development of drug resistance and adverse side effects remain significant challenges in cervical cancer treatment. Thus, repurposing existing drugs as multitargeted therapies for cervical cancer is an attractive approach. In this study, we extensively screened the complete prepared FDA-approved drugs and identified the repurposing potential of taxifolin, a flavonoid with known antioxidant and anti-inflammatory properties, as a multitargeted therapy for cervical cancer. We performed a computational analysis using molecular docking with various sampling algorithms, namely HTVS, SP, and XP algorithms, for robust sampling pose and filtered with MM/GBSA analysis to determine the binding affinity of taxifolin with potential targets involved in cervical cancer, such as Symmetric Mad2 Dimer, replication initiation factor MCM10-ID, TPX2, DNA polymerase epsilon B-subunit, human TBK1, and alpha-v beta-8. We then conducted MD simulations to investigate the stability and conformational changes of the complex formed between taxifolin and the mentioned proteins. Our results suggest that taxifolin has a high binding affinity ranging from − 6.094 to − 9.558 kcal/mol, indicating its potential as a multitargeted therapy for cervical cancer. Furthermore, interaction fingerprints, pharmacokinetics and MD simulations revealed that the Taxifolin-target complexes remained stable over the simulation period, indicating that taxifolin may bind to the targets for an extended period. Our study suggests that taxifolin has the potential as a multitargeted therapy for cervical cancer, and further experimental studies are necessary to validate our findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data availability

No associated data.

References

  1. Ahmad S, et al. In-silico analysis reveals quinic acid as a multitargeted inhibitor against cervical cancer. J Biomol Struct Dyn. 2022. https://doi.org/10.1080/07391102.2022.2146202.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Chen J, et al. Nanotechnology in the management of cervical cancer. Rev Med Virol. 2015;25:72–83. https://doi.org/10.1002/rmv.1825.

    Article  CAS  PubMed  Google Scholar 

  3. Cohen PA, et al. Cervical cancer. The Lancet. 2019;393(10167):169–82. https://doi.org/10.1016/s0140-6736(18)32470-x.

    Article  Google Scholar 

  4. Eddy DM. Screening for cervical cancer. Ann Intern Med. 1990;113(3):214–26. https://doi.org/10.7326/0003-4819-113-3-214.

    Article  CAS  PubMed  Google Scholar 

  5. Ghosh S, et al. Targeted drug delivery in cervical cancer: current perspectives. Eur J Pharmacol. 2022;917:174751. https://doi.org/10.1016/j.ejphar.2022.174751.

    Article  CAS  PubMed  Google Scholar 

  6. Gupta S, Gupta MK. Possible role of nanocarriers in drug delivery against cervical cancer. Nano Rev Exp. 2017;8(1):1335567.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ordikhani F, et al. Drug delivery approaches for the treatment of cervical cancer. Pharmaceutics. 2016;8(3):23.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Ahmad S, et al. Nanoinformatics and nanomodeling: recent developments in computational nanodrug design and delivery systems. In: Emerging nanotechnologies for medical applications. Amsterdam: Elsevier; 2023. p. 297–332.

    Chapter  Google Scholar 

  9. Ahmad S, et al. Illustrious implications of nature-inspired computing methods in therapeutics and computer-aided drug design. In: Nature-inspired intelligent computing techniques in bioinformatics. Singapore: Springer Nature Singapore; 2022. p. 293–308.

    Google Scholar 

  10. Alturki NA, et al. In-silico screening and molecular dynamics simulation of drug bank experimental compounds against SARS-CoV-2. Molecules. 2022;27(14):4391.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Alghamdi YS, et al. Unveiling the multitargeted potential of N-(4-Aminobutanoyl)-S-(4-methoxybenzyl)-l-cysteinylglycine (NSL-CG) against SARS CoV-2: a virtual screening and molecular dynamics simulation study. J Biomol Struct Dyn. 2022. https://doi.org/10.1080/07391102.2022.2110158.

    Article  PubMed  Google Scholar 

  12. Alzamami A, et al. Hemi-Babim and Fenoterol as potential inhibitors of MPro and papain-like protease against SARS-CoV-2: an in-silico study. Medicina. 2022;58(4):515.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):42717.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Hou J, et al. In silico analysis of ACE2 receptor to find potential herbal drugs in COVID-19 associated neurological dysfunctions. Nat Prod Commun. 2022. https://doi.org/10.1177/1934578X221118549.

    Article  Google Scholar 

  15. Karwasra R, et al. The incipient role of computational intelligence in oncology: drug designing, discovery, and development. In: Computational intelligence in oncology. Singapore: Springer; 2022. p. 369–84.

    Chapter  Google Scholar 

  16. Tripathi MK, et al. Fundamentals of molecular modeling in drug design. In: Computer aided drug design (CADD): from ligand-based methods to structure-based approaches. Amsterdam: Elsevier; 2022. p. 125–55.

    Chapter  Google Scholar 

  17. Ahmad S, et al. Multitargeted molecular dynamic understanding of butoxypheser against SARS-CoV-2: an in silico study. Nat Prod Commun. 2022. https://doi.org/10.1177/1934578X221115499.

    Article  Google Scholar 

  18. Ahmad S, et al. Mobile technology solution for COVID-19: surveillance and prevention. In: Computational intelligence methods in COVID-19: Surveillance, prevention, prediction and diagnosis. Singapore: Springer; 2021. p. 79–108.

    Chapter  Google Scholar 

  19. Ahmad S, et al. Therapeutic protein-based vaccines. In: Protein-based therapeutics. Singapore: Springer; 2023. p. 355–84.

    Chapter  Google Scholar 

  20. Ahmad S, et al. Reporting dinaciclib and theodrenaline as a multitargeted inhibitor against SARS-CoV-2: an in-silico study. J Biomol Struct Dyn. 2022. https://doi.org/10.1080/07391102.2022.2060308.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Yadav MK, et al. Predictive modeling and therapeutic repurposing of natural compounds against the receptor-binding domain of SARS-CoV-2. J Biomol Struct Dyn. 2022. https://doi.org/10.1080/07391102.2021.2021993.

    Article  PubMed  Google Scholar 

  22. Ahmad S, et al. Molecular dynamics simulation and docking analysis of NF-κB protein binding with sulindac acid. Bioinformation. 2022;18(3):170–9.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Balasubramanian B, et al. Exosomes as an emerging nanoplatform for functional therapeutics. In: Handbook on nanobiomaterials for therapeutics and diagnostic applications. Amsterdam: Elsevier; 2021. p. 483–98.

    Chapter  Google Scholar 

  24. Famuyiwa SO, et al. Comprehensive computational studies of naturally occurring Kuguacins as antidiabetic agents by targeting Visfatin. Chem Afr. 2023. https://doi.org/10.1007/s42250-023-00604-8.

    Article  Google Scholar 

  25. Karwasra R, et al. Macrophage-targeted punicalagin nanoengineering to alleviate methotrexate-induced neutropenia: a molecular docking, DFT, and MD simulation analysis. Molecules. 2022;27(18):6034.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Kaul T, et al. Probing the effect of a plus 1bp frameshift mutation in protein-DNA interface of domestication gene, NAMB1, in wheat. J Biomol Struct Dyn. 2019;38(12):3633–47.

    Article  PubMed  Google Scholar 

  27. Khan FN, Ahmad S, Raza K. Clinical applications of next-generation sequence analysis in acute myelogenous leukemia. In: Translational bioinformatics applications in healthcare. Boca Raton: CRC Press; 2021.

    Google Scholar 

  28. Khan FN, et al. A review on predictive systems and data models for covid-19. In: Computational intelligence methods in COVID-19: surveillance, prevention, prediction and diagnosis. Singapore: Springer; 2021. p. 123–64.

    Chapter  Google Scholar 

  29. Ramlal A, et al. From molecules to patients: the clinical applications of biological databases and electronic health records. In: Translational bioinformatics in healthcare and medicine. Amsterdam: Elsevier; 2021. p. 107–25.

    Chapter  Google Scholar 

  30. Shah AA, et al. Structure-based virtual screening, molecular docking, molecular dynamics simulation, and metabolic reactivity studies of quinazoline derivatives for their anti-EGFR activity against tumor angiogenesis. Curr Med Chem. 2023. https://doi.org/10.2174/0929867330666230309143711.

    Article  PubMed  Google Scholar 

  31. Sheikh K, et al. Consequential innovations in nature-inspired intelligent computing techniques for biomarkers and potential therapeutics identification. In: Nature-inspired intelligent computing techniques in bioinformatics. Singapore: Springer Nature Singapore; 2022. p. 247–74.

    Google Scholar 

  32. Tarique M, et al. Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and other coronaviruses: a genome-wide comparative annotation and analysis. Mol Cell Biochem. 2021;476:2203–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Yang M, et al. Insights into mad2 regulation in the spindle checkpoint revealed by the crystal structure of the symmetric mad2 dimer. PLoS Biol. 2008;6(3):e50.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Warren EM, et al. Physical interactions between Mcm10, DNA, and DNA polymerase α. J Biol Chem. 2009;284(36):24662–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Giesecke A, Stewart M. Novel binding of the mitotic regulator TPX2 (target protein for Xenopus kinesin-like protein 2) to importin-α. J Biol Chem. 2010;285(23):17628–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Suwa Y, et al. Crystal structure of the human Pol α B subunit in complex with the C-terminal domain of the catalytic subunit. J Biol Chem. 2015;290(23):14328–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Zhang C, et al. Structural basis of STING binding with and phosphorylation by TBK1. Nature. 2019;567(7748):394–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Campbell MG, et al. Cryo-EM reveals integrin-mediated TGF-β activation without release from latent TGF-β. Cell. 2020;180(3):490-501.e16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Release S. Protein preparation wizard. New York: Epik, Schrödinger, LLC; 2016. p. 2018–3.

    Google Scholar 

  40. Release S. 2017 Maestro. New York: Schrödinger, LLC; 2017.

    Google Scholar 

  41. Release S. Epik (2020). New York: Schrödinger Release; 2020. p. 1.

    Google Scholar 

  42. Schrödinger P. Version 3.5. New York: LLC; 2014.

    Google Scholar 

  43. Lu C, et al. OPLS4: Improving force field accuracy on challenging regimes of chemical space. J Chem Theory Comput. 2021;17(7):4291–300.

    Article  CAS  PubMed  Google Scholar 

  44. Release S. LigPrep. New York: Schrödinger, LLC; 2017.

    Google Scholar 

  45. Release S. Glide. New York: Schrödinger, LLC; 2018. p. 757.

    Google Scholar 

  46. Release S. QikProp. New York: Schrödinger, LLC; 2020. p. 329.

    Google Scholar 

  47. Lipinski CA. Lead-and drug-like compounds: the rule-of-five revolution. Drug Discovery Today Technol. 2004;1(4):337–41.

    Article  CAS  Google Scholar 

  48. Release S. Desmond molecular dynamics system, DE Shaw research. In: Maestro-desmond interoperability tools. New York: Schrödinger; 2017.

    Google Scholar 

  49. McDonald I. NpT-ensemble Monte Carlo calculations for binary liquid mixtures. Mol Phys. 1972;23(1):41–58.

    Article  CAS  Google Scholar 

Download references

Funding

The authors are thankful to the Deanship of Scientific Research at Najran University for funding this work under the General Research Funding program grant code number (NU/DRP/MRC/12/8).

Author information

Authors and Affiliations

  1. Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Najran University, Najran, 61441, Kingdom of Saudi Arabia

    Hassan Hussain Almasoudi & Mutaib M. Mashraqi

  2. Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Al-Quwayiyah, Shaqra University, Riyadh, 15526, Kingdom of Saudi Arabia

    Mohammed Ageeli Hakami

  3. Department of Clinical Pharmacy, Umm Al-Qura University, Makkah, 21955, Kingdom of Saudi Arabia

    Abdulfattah Y. Alhazmi

  4. Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, King Khalid University, Abha, 62223, Kingdom of Saudi Arabia

    Mohammed Makkawi & Sultan Alasmari

  5. Department of Biology, Turabah College, Taif University, Taif, 21944, Kingdom of Saudi Arabia

    Youssef Saeed Alghamdi

Authors
  1. Hassan Hussain Almasoudi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohammed Ageeli Hakami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Abdulfattah Y. Alhazmi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mohammed Makkawi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sultan Alasmari
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Youssef Saeed Alghamdi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mutaib M. Mashraqi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mutaib M. Mashraqi.

Ethics declarations

Competing interest

The authors declare no competing or conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Almasoudi, H.H., Hakami, M.A., Alhazmi, A.Y. et al. Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: an extensive MM\GBSA-based screening, and MD simulation study. Med Oncol 40, 218 (2023). https://doi.org/10.1007/s12032-023-02094-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-023-02094-7

Keywords

Search

Navigation